A small molecule that relays signals from a receptor to one or more targets inside a cell. The signal often originates outside the cell, although intracellular signals are also transmitted by second messengers in bacteria.
All organisms must respond to environmental changes, and the signal transduction pathways that allow them to do so on a cellular level are essential for the control of processes ranging from chemotaxis to cell differentiation and apoptosis [1] [2] [3] [4] . This signalling is mediated by a vast array of small, soluble signalling molecules, both within and outside cells 5, 6 . Some of these molecules, such as the hormone-like acyl-homoserine lactone auto inducers that control quorum sensing in Gramnegative bacteria, diffuse across cell membranes from the extracellular milieu to directly control gene expression 5 . However, many environmental signalling pathways rely on second messenger molecules to relay external signals from membrane receptors to one or more effectors within the cell. Second messengers include such diverse molecules as cyclic nucleotides, guanosine pentaphosphate and guanosine tetraphosphate (collectively referred to as (p)ppGpp), Ca 2+ , inositol trisphosphate and diacylglycerol [7] [8] [9] [10] [11] [12] . The cyclic nucleotide cyclic AMP was the first second messenger to be described, and it is also the most broadly used. cAMP is generated from ATP by adenylyl cyclases (ACs), and phosphodiesterases (PDEs) catalyse its hydrolytic degradation (FIG. 1) . ACs are divided into six classes based on primary amino acid sequence. Although class III is the largest and most diverse group, and includes all known ACs from eukaryotes and many from bacteria 7, [13] [14] [15] , the well-studied Escherichia coli AC belongs to class I. The downstream regulatory effects of cAMP are mediated through allosteric interactions with cAMP-binding proteins, which induce conformational changes that result in alterations in the activation states of these binding partners.
Regulation of gene expression is a major outcome of cAMP signalling, but the mechanisms involved differ between bacterial and eukaryotic cells 16, 17 . In bacteria, transcription factors of the cAMP-receptor protein family (Crp family) are activated by direct binding of cAMP, whereas in eukaryotic cells cAMP-mediated activation of transcription factors often requires the protein kinase A complex (PKA) as an intermediate. In this case, cAMP binding to regulatory subunits in PKA liberates the catalytically active kinase subunits, which activate transcription factors by phosphorylation.
cAMP was first discovered when its role in hormone signal transduction in eukaryotic cells was identified 18 . The biological processes that are now known to be controlled by cAMP signalling in eukaryotes range from metabolism to memory formation and innate immunity 16, 19 . cAMP was subsequently also discovered in bacteria, and its role in mediating the 'glucose response' , or catabolite repression, has been extensively studied in E. coli 17, 20 . The cAMP-Crp complex is needed for activation of the lac operon (encoding proteins that allow lactose to be used as a secondary carbon source), but during catabolite repression the presence of glucose reduces cAMP production, and expression of the lac operon is inhibited 21 . However, an increasing recognition of the roles of cAMP in microbial virulence, ranging from a potent toxin to a master regulator of virulence gene expression, has generated new interest in this second messenger. 
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Effectors
Downstream functional targets that are activated by second messengers in response to specific signal transduction events. The same term is also used to refer to virulence factors that are injected into host cells by bacterial secretion systems.
cAMP receptor protein family (Crp family). A family of global regulatory factors that contain cyclic AMP-binding and DNA-binding domains and are associated with positive and negative gene regulation in some bacteria. Binding of cAMP typically induces a conformational change that increases the DNA-binding activity of Crps.
Cyclic di-GMP
A second messenger that is used exclusively in bacteria and has been associated with regulation of biofilm formation, motility and expression of virulence factors.
The near universal use of cAMP signalling in life forms as diverse as bacteria, archaea, fungi, eukaryotic parasites and mammals provides unique opportunities for cAMP-mediated modulation of host-pathogen interactions. Many of these interactions are only just being discovered. The essential roles of cAMP in eukaryotic signal transduction and bacterial catabolite repression have been reviewed previously [14] [15] [16] [17] 21 . In this Review, we focus on the multiple roles of cAMP in pathogen biology, with an emphasis on its importance in virulence gene regulation, host-pathogen interactions and the response of pathogens to their host environments.
Cyclic AMP signalling in pathogenic bacteria
The discovery of host-dependent AC toxins, which are secreted into host cells by several pathogens during infection, provided the first example of the role of cAMP in bacterial virulence 14, 22 . More recently, it has become evident that cAMP is involved in other processes, as disruption of intracellular cAMP signalling attenuates virulence in numerous bacterial pathogens [23] [24] [25] [26] [27] . cAMP has central roles in regulating biofilm formation, type III secretion, carbon metabolism and virulence gene regulation in many pathogens. In addition, several new strategies by which pathogens can modulate cAMP levels within host cells have recently been discovered 28, 29 . Glucose depletion induces AC activity in some, but not all, bacteria, and the use of Crp-family transcription factors as a primary means of relaying the message is common. Much of the cAMP signalling diversity within bacteria occurs at the level of cAMP-associated regulatory targets, which vary between organisms. The effects of cAMP are amplified in some cases by cAMPmediated co-regulation of other global regulators. For example, expression of the stress-associated global regulator RNA polymerase σ-factor S (σ S ; encoded by rpoS) is controlled by cAMP-Crp in Vibrio vulnificus, E. coli and Salmonella enterica [30] [31] [32] . In the case of V. vulnificus, transcriptional repression of rpoS occurs by direct binding of the cAMP-Crp complex to two binding sites in the rpoS promoter 30 . Similarly, cAMP levels control biofilm production in Vibrio cholerae, partly through regulation of a diguanylyl cyclase that is responsible for the production of another second messenger, cyclic di-GMP
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In some pathogenic bacteria, a cAMP-Crp interaction integrates the expression of horizontally acquired genes (located in plasmids or genomic islands) into existing regulatory networks, possibly owing to the broad use of this interaction across many unrelated species. For example, in Yersinia pestis, Crp directly activates expression of plasminogen activator (pla), a plasmid-encoded virulence gene that facilitates infection of the mammalian host following either flea bite or aerosol transmission 34 . Plasticity is evident in this adaptive process, as cAMP-Crp activates protein secretion from each of three type III secretion systems (T3SSs) in Yersinia enterocolitica 24 , which encodes proteins required for biogenesis of the virulence-associated toxin-co-regulated pilus (TCP).
In this section, we describe three examples of both the extent and significant diversity of cAMP-associated gene regulation in bacterial pathogens.
Pseudomonas aeruginosa. cAMP has an integral and multifaceted role in Pseudomonas aeruginosa pathogenesis, as this bacterium expresses three ACs: CyaA, CyaB and ExoY. ExoY is a host-activated AC toxin that is exported, along with several other proteins, into host cells through a cAMP-regulated T3SS 37, 38 , and is discussed in detail later. CyaA and CyaB remain within the P. aeruginosa cytosol, where they increase the intracellular levels of cAMP to control virulence gene expression (FIG. 2) . Vfr controls the expression of many virulence-associated genes in P. aeruginosa, including the genes encoding exotoxin A, type IV pili, a T3SS and the las quorum sensing system 43 . All of these genes except lasR are regulated by Vfr in a cAMP-dependent manner. Surprisingly, expression of lasR requires Vfr but is not affected by intracellular cAMP levels 43 . Rather, Vfr seems to require a cAMP-independent cofactor for lasR induction, raising the possibility that Vfr is a dual regulator that can control different gene sets in response to various environmental conditions. The cAMP-Vfr complex also upregulates the expression of the PDE CpdA 44 , as well as a second cAMP-binding protein, CbpA 45 . CpdA degrades cAMP as a counterbalance to cAMP synthesis by the ACs and is required for proper expression of virulence factors 44 . The functions of CbpA are unknown, although its cAMPdependent polar localization in the cell is intriguing and suggests that additional roles for cAMP in P. aeruginosa await discovery.
Vibrio cholerae. Cholera toxin (CT) disrupts cAMP signalling in host intestinal epithelial cells during infection, causing the watery diarrhoea that characterizes cholera. However, the fact that cAMP signalling is important throughout the entire V. cholerae infection cycle is much less appreciated. Recent studies have shown that cAMP signalling in V. cholerae integrates carbon source availability with population density, biofilm formation, resistance to bacteriophages and virulence gene expression (FIG. 3) .
Vibrio spp. have a single AC, CyaA, that mediates signalling through Crp 46 . Glucose limitation stimulates production of cAMP by CyaA
47
, and this cAMP binds Crp to form the active transcription factor cAMP-Crp. In V. cholerae, cAMP-Crp increases the concentration of the master quorum sensing regulator, HapR, which in turn stimulates quorum sensing and also inhibits biofilm formation and the expression of CT and the TCP 
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A regulatory mechanism that allows reversible toggling between two stable states.
HapR expression requires the presence of two auto inducers, cholera autoinducer 1 (CAI-1) and autoinducer 2 (AI-2), which are extracellular signalling molecules secreted by V. cholerae 52 . cAMP-Crp promotes CAI-1 production by activating the expression of cqsA, which encodes CAI-1 synthase. The key role of cAMP in linking carbon source to population density in V. cholerae was further confirmed by the finding that the cell density needed to activate HapR increases when the intracellular levels of cAMP are decreased by the addition of glucose to the culture 53 . Interestingly, the regulation of CqsA expression by cAMP-Crp seems to act at the level of mRNA stability, although the mechanism involved in this post-transcriptional regulation has not been determined 53 . cAMP also modulates V. cholerae pathogenesis by HapR-independent mechanisms. Such mechanisms may be important in the V. cholerae El Tor strains, which lack a functional HapR owing to the presence of a frameshift mutation 54 . For example, cAMP-Crp downregulates the expression of CdgA, a cyclic diguanylyl cyclase that promotes biofilm formation through c-di-GMP production 33 . Moreover, cAMP-Crp forms a bistable switch with the transcription factor ToxT (also known as TcpN), a protein that controls CT and TCP expression during infection 36 . This regulatory switch may allow a subpopulation of V. cholerae cells in rice water stool to remain in a hyper-infectious state by retaining their expression of CT and TCP for up to 5 hours outside the host, which would allow increased transmission during epidemics without compromising the fitness of V. cholerae outside the host. In addition, cAMP-Crp signalling promotes the resistance of V. cholerae O1 strains to environmental bacteriophages, thus providing another means by which cAMP may contribute to V. cholerae fitness outside the host . These accessory domains probably regulate AC activity and may add additional biological functions.
Except when added at high concentrations, glucose has little effect on M. tuberculosis cAMP levels 63,64 . Instead, M. tuberculosis ACs are regulated at multiple levels by a range of conditions that are encountered within the host. For example, the activity of M. tuberculosis ACs is directly affected by pH, fatty acids and carbon dioxide (CO 2 ), and the expression of AC-encoding genes is controlled by hypoxia and starvation 28 . In particular, macrophage passage stimulates the activity of M. tuberculosis ACs, raising cAMP levels as much as 50-fold in 2 hours compared with incubation in tissue culture media alone 63 . Viable mycobacteria also secrete cAMP into their host macrophages during infection, as discussed below. One AC, Rv0386, has been specifically linked to the production and secretion of cAMP within macrophages (FIG. 4) , and deletion of the corresponding gene decreases M. tuberculosis virulence and pathology in mice 65 . In addition to its complex array of ACs, M. tuberculosis possesses ten putative cAMP-binding proteins 28, 57, 58 . These include two Crp-family transcription factors and a protein lysine acetylase 25,66-68 . One of the two cAMP-Crp represses biofilm formation by downregulating the cyclic diguanylyl cyclase CdgA, a protein that leads to the production of cyclic di-GMP and therefore enhances biofilm formation. cAMP also upregulates the cholera autoinducer 1 (CAI-1) synthetase CqsA, and CAI-1 then induces expression of the major quorum sensing regulator, HapR. HapR induces quorum sensing, and simultaneously represses biofilm formation by inhibiting the biofilm gene activator VpsR. It also inhibits the expression of cholera toxin (CT)-encoding genes (ctxAB) and toxin-co-regulated pilus (tcp) genes by downregulating aphA. The toxin regulator ToxT activates ctxAB and the tcpABCDEF genes, and cAMP-Crp therefore forms a bistable switch with ToxT for CT and TCP production. The involvement of cAMP-Crp in phage resistance is expected to involve bacterial surface components, which is consistent with the role of cAMP-Crp in regulating the expression of outer-membrane protein T (OmpT). , and current efforts are aimed at determining which of its regulon members specifically contribute to virulence. The second transcription factor, Cmr, controls the expression of a different set of genes in response to cAMP levels and macrophage passage 67 . The roles of the cAMP-responsive lysine acetylase and the remaining seven putative cAMP-binding proteins have yet to be characterized.
Bacterial manipulation of host cyclic AMP levels Disruption of host cell signal transduction pathways is an effective virulence strategy used by many pathogens, and the myriad ways in which cAMP levels affect immune function make cAMP signalling a frequent target within host cells 19 (FIG. 5) . Elevated levels of cAMP can suppress innate immune functions by modulating the expression of inflammatory mediators, dampening the phagocytic response and reducing intracellular killing of ingested pathogens 19 . Another powerful effect of elevated cAMP levels in host intestinal epithelial cells is the excessive fluid secretion that causes the watery diarrhoea associated with cholera and some toxigenic E. coli infections 69, 70 . The best studied microbial strategy for elevation of host cAMP levels is the production of certain toxins by bacteria 40, 69, 70 . These toxins can be ACs themselves, as is the case for the AC toxin of Bordetella pertussis (CyaA), the oedema factor (EF) toxin of Bacillus anthracis and ExoY of P. aeruginosa. Alternatively, toxins such as CT, pertussis toxin (PT) from B. pertussis or heat-labile enterotoxin (LT) from E. coli can modulate the activity of the endogenous host ACs by altering the function of heterotrimeric guanine-nucleotide-binding proteins (G proteins) that, in turn, regulate host AC activity. Elevation of host cAMP concentrations by bacterial pathogens also occurs by toxin-independent mechanisms, as discussed below. Some bacterial pathogens even use multiple simultaneous strategies to elevate host cAMP levels. For example, B. pertussis secretes two toxins (CyaA and PT), each of which increases cAMP synthesis in the host cell by a different mechanism. The end result of such a twopronged approach is reduced phagocytosis and decreased production of reactive oxygen intermediates by intoxicated macrophages, along with suppression of neutrophil recruitment to the lungs during infection 71, 72 . Adenylyl cyclase toxins. B. anthracis and B. pertussis both produce and export calmodulin-dependent AC toxins (EF and CyaA, respectively), which become active in host cells only after binding the host calcium-binding protein calmodulin 69 (FIG. 5a) . P. aeruginosa also exports a host-dependent AC toxin (ExoY) that is activated by an unidentified host factor 37 (FIG. 5a) . A secreted AC has also been identified in Y. pestis, although it has not been characterized . Despite their mechanistic similarities, CyaA and EF have different protein structures, enzyme kinetics, localization in the host cell and interactions with calmodulin 77, 78 . CyaA is a single polypeptide that inserts into the plasma membrane of target cells 79 . By contrast, EF is the toxic component of an AB toxin (oedema toxin (ET)) that is taken up by receptor-mediated endocytosis and ultimately released into the host cytosol, where it typically resides in a perinuclear location 80 . CyaA and EF affect T helper (T H ) cell development: at low levels, they promote a T H 1-to-T H 2 switch, whereas at high levels all T cell differentiation is suppressed 77 . The T H 1-to-T H 2 shift occurs when the cAMP produced by the toxins activates a PKA pathway that increases the production of T H 2 cytokines such as interleukin-10 (IL-10) and IL-4. However, this same pathway also reduces the expression of IL-12, a key cytokine involved in development of the kind of T H 1 cell-mediated immune response that is required for clearance of many pathogens. Structural comparisons of EF with host ACs has led to the identification of two inhibitors that specifically target EF and may be candidates for post-exposure treatment 81 .
Toxins that upregulate the activity of host adenylyl cyclases. A second approach for increasing the cAMP levels in host cells is to modify the α-subunits of heterotrimeric G proteins that regulate the activity of host ACs 19, 40, 70 . V. cholerae CT, E. coli LT and B. pertussis PT are ADP-ribosylating enzymes that target different regulatory G protein subunits (FIG. 5b) . CT and LT target the stimulatory Gα s subunits, effectively locking them into an active mode that causes continuous production of cAMP by host ACs. By contrast, the ADP-ribosylating activity of PT inactivates the inhibitory Gα i subunits, preventing them from downregulating AC activity. In all cases, the result is constitutive AC activity, which leads to the accumulation of cAMP within host cells. (FIG. 5c) ; cAMP levels within macrophages increase 2-3-fold following infection with viable, but not heat-killed, M. tuberculosis-complex bacteria 28,63,65 . Increased levels of cAMP within infected macrophages correlate with decreased phagolysosome fusion 82 , reduced pathology and attenuated virulence 65 . Using 14 C-radiolabelled M. tuberculosis, the increase in cAMP was shown to be mediated by the bacteria rather than by the host macrophages, and it is largely due to synthesis by a specific AC (Rv0386) 65 . The mechanism for cAMP secretion is not known, but it is regulated separately from cAMP production 63 . Albumin inhibits both the production and secretion of cAMP in M. tuberculosis-complex bacteria grown in vitro. Oleic acid restores cAMP production but not secretion in these bacteria, resulting in high levels of cytoplasmic cAMP 63 . Identification of the secretory mechanism and its regulation is key to unravelling the specific roles of cAMP in tuberculosis.
Secretion of cyclic AMP into host cells. M. tuberculosis secretes cAMP directly into host macrophages following infection
Exploiting host signalling via complement-Toll-like receptor 2 crosstalk. Porphyromonas gingivalis provides an additional example of a method by which a pathogen can directly increase cAMP levels in host cells (FIG. 5d) . P. gingivalis expresses a protease that has complement C5 convertase-like activity and cleaves the host complement protein C5 into its active C5a and C5b components. C5b is degraded to prevent stimulation of an inflammatory response, and C5a binds to C5a receptor (C5aR). At the same time, intact P. gingivalis binds to Toll-like receptor 2 (TLR2) and CXC-chemokine receptor 4 (CXCR4) on macrophages. The coordinate stimulation of C5aR and TLR2 in association with CXCR4 triggers cAMP production in the host cell, with subsequent PKA activation that leads to downregulation of the inducible nitric oxide synthase (iNOS) killing pathway and a concomitant reduction in the concentration of the antimicrobial nitric oxide 29 . (FIG. 6) . In contrast to mammalian cells, which contain many different ACs, each of which can be controlled by a specific signal, fungi possess only one, extremely versatile AC that can process and integrate environmental signals from a variety of sources. This single AC is required for virulence in many pathogenic fungi, including the human pathogens Cryptococcus neoformans 83 , Candida albicans 84 and Aspergillus fumigatus 85 , as well as the rice pathogen Magnaporthe oryzae 86 . The role of cAMP-PKA signalling in virulence has been best studied in C. neoformans and C. albicans 83, 87 .
Cryptococcus neoformans. C. neoformans is a dimorphic basidiomycete that causes fungal meningoencephalitis, particularly in immunocompromised individuals 88 . Essential virulence determinants of C. neoformans include the antioxidant melanin and an antiphagocytic capsule 83 . The single AC present in C. neoformans, Cac1, is a membrane-bound protein that is dispensable for in vitro growth but essential for virulence 89 . Genetic analyses have shown that cAMP production by Cac1 is activated by the Gα subunit Gpa1 following stimulation of the GPCR Gpr4 by amino acids 90 (FIG. 6a) . Transcriptome analyses have shown that the Ras and cAMP-PKA signalling pathways are largely independent from one another in C. neoformans, although both contribute to antifungal drug susceptibility 91 . Nonetheless, regulation of mating and hyphal differentiation requires AC-associated protein 1 (Aca1), which is a positive regulator of Cac1, and this might involve input from the Ras signalling pathway.
In the absence of cAMP, PKA exists as an inactive tetrameric complex that includes two regulatory (Pkr1) and two catalytic (Pka1) subunits. cAMP binding to PKA causes the Pkr1 subunits to release active Pka1, which then phosphorylates effector proteins such as the , produced from CO 2 (with the aid of carbonic anhydrase 2 (Can2) at low CO 2 concentrations). cAMP levels are decreased by the GTPase-activating protein Crg2 and phosphodiesterase 1 (Pde1). cAMP signalling affects the activity of PKA (consisting of regulatory subunit Pkr1 and catalytic subunit Pka1), and active Pka1 induces the transcription factor Nrg1, leading to virulence factor production. b | In C. albicans, the AC Cyr1 is activated by Grp1-Gpa2, HCO 3 -, serum, and muramyl dipeptides (MDPs) from other commensal or pathogenic bacteria. MDPs bind to Cyr1 directly to activate it in a trimeric complex with globular actin (G-actin) and the cyclase-associated protein Cap1. Serum-mediated activation also occurs through Ras1 to further enhance the MDP activation pathway. Tpk1 and Tpk2, the two catalytic subunits of PKA, control downstream effects of cAMP signalling, including the activation of transcription factors enhanced filamentous growth protein (Efg1) and Flo8, which lead to virulence factor production. 
Globular actin
Individual actin subunits that polymerize into the long actin filaments which contribute to many eukaryotic processes, including maintenance of cell structure, motility, cell division and cell signalling.
transcription factor Nrg1 and thus regulates downstream functions, including virulence gene expression 92, 93 . In addition, maintaining the homeostasis of the cAMP-PKA system requires a means of decreasing cAMP levels. Such negative inputs include inhibition of Gpa1 by Crg2, a GTPase activator protein (GAP), to reduce cAMP production, and hydrolysis of cAMP by Pde1, a PDE 83 . Although little is known about the downstream targets of the cAMP-PKA pathway, the essentiality of this signalling pathway for virulence gene regulation in C. neoformans serotype A is clear. Deletion of any of the genes encoding components of the regulatory cascade such as Gpa1, Cac1 and Pka1 results in loss of melanin, capsule production and virulence 83, 94 . Conversely, pkr1 -/-mutants of C. neoformans are hypervirulent 89, 95 . An alternative way to activate the cAMP-PKA pathway in C. neoformans is with CO 2 or HCO 3 − , consistent with the role of CO 2 in stimulating capsule production 96 . Cac1 is directly activated by CO 2 or HCO 3 − , and this effect is independent of G protein-mediated regulation of Cac1 by Gpa1 (REFS 97, 98) . In aqueous solution, CO 2 exists in equilibrium with HCO 3 − , and at low CO 2 concentrations the conversion of CO 2 into HCO 3 − is catalysed by carbonic anhydrases. C. neoformans produces two such enzymes, carbonic anhydrase 1 (Can1) and Can2 (REF. 99 ). Can2, but not Can1, is required for growth in vitro, during which CO 2 levels are low (~0.033%), and this dependence on Can2 is relieved by high levels of CO 2 . Palmitate supplementation also rescues in vitro growth of can2 -/-mutants, suggesting a role for Can2 in fatty acid metabolism 97, 99 . However, neither carbonic anhydrase is required for virulence, presumably because of the high levels of CO 2 (~5%) present within mammalian hosts 99 . Future studies are needed to address the specific roles of CO 2 versus HCO 3 − in Cac1 activation, and whether the means by which the cAMP-PKA pathway is stimulated confers any specificity on the downstream effector functions that are affected.
Candida albicans. The cAMP-PKA signalling pathway is highly conserved among fungi, but each system has its own signalling specificities and controls different functions. C. albicans is a commensal ascomycete that causes serious disease in immunocompromised individuals 100 . The yeast-to-filament transition that is crucial for C. albicans virulence is regulated by the cAMP-PKA pathway (FIG. 6b) , although using G protein pathways that are different from those used by C. neoformans.
In contrast to C. neoformans Cac1, the single AC of C. albicans, Cyr1 (previously called Cdc35), is directly activated by the G protein Ras1 in response to glucose, serum and N-acetylglucosamine, leading to hyphal growth 84 . This direct activation takes place by Ras1·GTP binding to a Ras association (RA) domain of Cyr1, and therefore differs from what has been observed in C. neoformans, in which the cAMP-PKA pathway seems to be largely independent of Ras signalling 91, 101 . Two catalytic subunits of PKA, Tpk1 and Tpk2, regulate downstream events in response to cAMP production in C. albicans. Tpk2 is the primary kinase responsible for hyphal growth and virulence, whereas Tpk1 controls stress responses 102, 103 . Following activation by Tpk2, the transcription factors enhanced filamentous growth protein (Efg1) and Flo8 regulate virulence gene expression 104 . The AC-cAMP signalling pathway in C. albicans can also be activated in vitro by amino acids through the heterotrimeric GPCR Gpr1 and its associated G protein α-subunit, Gpa2 (REF. 105 ). However, the mechanism by which this activation pathway causes hyphal growth in C. albicans has not been described.
In contrast to the differential use of G proteinactivation pathways in C. albicans and C. neoformans, AC activation by CO 2 or HCO 3 − and the importance of carbonic anhydrases at low CO 2 concentrations is similar in these species 98, 99 , as demonstrated by the successful complementation of the hyphal growth deficiency of a C. albicans cyr1 -/-mutant by expressing Cac1 from C. neoformans 97 . The activation of Cyr1 by CO 2 or HCO 3 − is independent of G protein signalling and occurs by direct binding to the catalytic domain of Cyr1.
CO 2 induces the development of hyphae and pseudohyphae and the invasion of underlying agar in C. albicans but not in non-pathogenic Candida spp., making this phenotype a specific biomarker for pathogenicity 98 . CO 2 generated by C. albicans cells can accumulate to levels that are sufficient to induce invasive hyphal growth, providing numerous ways in which CO 2 can contribute to pathogenesis 87 . Although hyphal growth is essential for virulence, the ability of C. albicans to switch between yeast and hyphal forms is also crucial for pathogenesis, as mutations that lock cells in either yeast or filamentous forms lead to virulence attenuation 106 . Similarly, set3
-/-mutants, in which loss of the Set3C histone deacetylase complex causes hypersensitivity to filamentation signals, are avirulent 107 . The multiple ways in which disruption of the cAMP-PKA signalling pathway attenuates virulence make it a promising target for the development of antifungal drugs.
Serum is one of the most potent stimulators of hyphal growth in C. albicans, and muramyl dipeptides (MDPs) derived from the breakdown of cell wall peptidoglycan from simultaneously infecting or commensal bacteria were recently shown to be crucial for this activation 108 . MDPs stimulate cAMP production in C. albicans by binding to leucine-rich repeats (LRRs) within Cyr1. Ras1 contributes to Cyr1 activation in response to serum, but full activation of hyphal growth by this pathway also involves the sensing of globular actin (G-actin) pools, as extensive remodelling of the actin cytoskeleton is required for hyphal development. Cyr1 does not directly bind G-actin but is able to integrate the serum, MDP and actin signals as part of a tripartite complex with G-actin and the cyclase-associated protein Cap1 (REFS 87, 109) . Cap1 binds both Cyr1 and G-actin, serving as a bridge between them. The discovery that MDPs from commensal and/or simultaneously infecting bacteria are direct enhancers of C. albicans pathogenesis is a reminder of the complexity of the microbial interactions within the human host. It also has important implications for treatment of both bacterial and fungal infections, as antibiotic therapies that increase fragmentation of the bacterial cell wall might specifically trigger or exacerbate a fungal infection. Nature Reviews | Microbiology parasites that is generated in the mosquito and transmitted to the mammalian host, where it infects a hepatocyte.
Gametocyte
The sexual form of Plasmodium spp. parasites. Gametocytes are generated within infected erythrocytes in the mammalian host and are transmitted to the mosquito.
Cyclic AMP signalling in parasitic protozoa
Parasites also need accurate signalling mechanisms to sense and respond to new conditions as they move between mammalian hosts, insect vectors and the environment. Frequently, a membrane receptor senses the environment and activates signalling pathways to trigger an immediate response, such as motility or exocytosis, but also a delayed response, such as cell division or differentiation into the next developmental stage. cAMP is emerging as a central signalling mediator that regulates essential processes in parasites. Evidence for an evolutionarily conserved cAMP signalling pathway is abundant in protozoa of the genera Plasmodium, Leishmania, Trypanosoma, Toxoplasma and Entamoeba, as well as in the parasitic worm genus Schistosoma; together, species from these genera cause the majority of human mortality and morbidity worldwide.
Modulation of cyclic AMP levels in the host cell. Intracellular parasites frequently induce signalling cascades in the host cell that facilitate invasion. For example, Trypanosoma cruzi stimulates Ca 2+ and cAMP signalling in the host cell to induce the recruitment and fusion of host cell lysosomes, which the parasite requires for invasion 110 . Another parasite strategy for survival is evasion of the host immune system. In this case, cAMP has been implicated in Plasmodium spp. evasion of Kupffer cells, whereby parasites induce an increase in cAMP that mediates inhibition of the microbicidal respiratory burst and, as a consequence, results in the survival of the parasite 111 .
Host cell invasion by the malaria parasite. Plasmodium spp., the causative agents of malaria, initially infect the hepatocytes of the host but continue by invading and replicating in erythrocytes. In both the liver and blood stages, Plasmodium spp. use cAMP pathways to regulate the processes required to establish a successful infection. During the liver stage, activation of an AC, ACα, in the Plasmodium spp. sporozoite increases intracellular cAMP and induces exocytosis, which results in the exposure of proteins required for hepatocyte invasion 112 (FIG. 7) .
The ACα protein of Plasmodium spp. contains a domain that has homology to K + channels, and this domain is thought to be functionally linked to AC activity. In addition, motility induced by albumin in sporozoites is regulated by cAMP 113 .
In the blood stage, cAMP signalling pathways have been implicated in intra-erythrocyte survival, regulation of the parasite cell cycle and invasion of host cells. At this stage, Plasmodium spp. replicate in a synchronous manner, and this replication is responsible for the cyclical fevers that characterize malaria. The mechanism underlying this phenomenon is a melatonin-activated cAMP signalling cascade that regulates the cell cycle, resulting in synchronized replication 114, 115 . The permeability of the host erythrocyte membrane, which allows intake of the nutrients required for parasite survival and replication, is also regulated by cAMP. A cAMP-dependent PKA regulates anion channel conductance in the membrane of the infected erythrocyte, and this in turn controls parasite growth 116 . Invasion of host erythrocytes is also regulated by PKA, which phosphorylates apical membrane antigen 1 (AMA1), a protein that is present on the parasite surface and mediates erythrocyte invasion 117 . In addition to the role in host cell invasion, cAMP is required in Plasmodium spp. for the transition from the asexual form to the gametocyte, a step that appears to be regulated by cAMP signalling pathways [118] [119] [120] . PKA has also been implicated in stage transition from an actively replicating form into the quiescent, chronic stage in Toxoplasma gondii 121 , a parasite related to Plasmodium spp.
Stage transition of trypanosomatids and other parasites. cAMP signalling pathways have been described in T. cruzi, the causative agent of Chagas disease, and Trypanosoma brucei, the causative agent of human African trypanosomiasis. In T. cruzi, cAMP regulates PKA with striking effects on cell survival 122 and cell proliferation, through the inhibition of DNA, RNA and protein synthesis 123 . cAMP has also been implicated in the transition from the human-infective form of T. cruzi to the insectinfective form 124, 125 . In addition, a PDE regulates osmosis in the insect-infective form of this parasite 126 . In T. brucei, cAMP regulates parasite virulence 127 and induces the cell cycle arrest that occurs during differentiation from the human-infective stage into the insect-infective stage 128 . In the related parasites of the genus Leishmania, cAMP also seems to regulate stage transition 129 and motility 130 . Entamoeba spp., the causative agents of amoebiasis, are other examples of parasites in which cAMP-dependent pathways seem to regulate stage transition, in this case from the form living in the host intestine to the free-living cyst 131 . In Schistosoma spp., cAMP-mediated pathways are also present and are essential for parasite survival 132 .
There is growing evidence for the use of cAMP signalling pathways in processes required for parasite survival. Although the functional processes involved are diverse, transition to a different stage of the life cycle and invasion of the host cell are commonly regulated by cAMP. This is not surprising, as both events require a specific response to the environment that will facilitate survival of the parasite. From this point of view, cAMP-regulated pathways, which involve proteins that are related (but not identical) to proteins in the human host, appear to be promising pharmacological targets for drug development.
Conclusions and future directions cAMP signalling controls a surprisingly diverse range of processes in pathogenic bacteria, fungi and protozoa, and the crucial roles for cAMP in microbial pathogenesis extend from functions within the pathogens themselves to functions within their mammalian host cells. cAMP is a key regulator of virulence gene expression in bacteria and fungi through its influence on the activity of transcription factors. The regulation of virulence gene expression by cAMP-dependent transcription factors and the environmental control of cAMP production together allow pathogens to coordinate their gene expression programmes with the presence of appropriate environmental signals from their hosts. The modulation of cAMP levels within host cells by bacteria and protozoa contributes to the pathogenesis of these organisms by suppressing host immune responses while facilitating pathogen invasion, colonization and transmission. The success of this strategy is evident from the number of bacterial species that have independently evolved such mechanisms -ranging from direct secretion of cAMP or bacterial ACs into the host cells, to manipulation of the host cAMP production pathways. The frequent integration of horizontally acquired virulence genes into existing cAMP-controlled regulatory circuits also suggests that cAMP-mediated signalling facilitates the evolution of virulence in some pathogenic microorganisms.
Despite some general themes such as the presence of Crp-family transcription factors in bacteria and of cAMP-PKA-regulated transcription factors in fungi and protozoa, cAMP signalling pathways are complex, and there is a great deal of diversity among cAMP-associated regulatory circuits in different pathogens. Much of this diversity probably arises from the participation of regulatory cofactors, and recent evidence suggests that many cofactors involved in the activation of ACs and in cAMPdependent gene regulation remain to be discovered. The recent discovery of the CRTC (cAMP-regulated transcriptional co-activator) and PKA-independent cAMP-responsive EPAC (exchange proteins activated by cAMP) families of transcription factors in eukaryotes 15, 16, 75 , as well as the presence of cAMP-binding proteins other than transcription factors in bacteria such as P. aeruginosa and M. tuberculosis, suggests that there are additional levels of complexity that should be investigated. Characterizing these factors and deciphering their regulatory functions will probably establish new cAMP signalling paradigms in both bacteria and fungi.
In addition, cAMP signalling has an important role in sensing and responding to host signals. In some but not all cases, Crp-mediated gene expression is coordinated with carbon source availability in the host. CO 2 and Ca 2+ are additional signals used by multiple pathogens to sense the host environment through their AC-cAMP signalling systems. Fungi and mycobacteria express CO 2 -responsive ACs, whereas ACs from P. aeruginosa, B. pertussis and B. anthracis are Ca 2+ sensitive. Another example of cAMP signalling being used by pathogens to sense the host environment is the peptidoglycan sensitivity of C. albicans. This ability of an opportunistic pathogen to sense and exploit a polymicrobial infection is especially intriguing and has important implications for treatment. The possibility that other pathogens have similar abilities should be investigated.
The specificity of cAMP signalling is a crucial issue for pathogens with multiple ACs and also for host cells. M. tuberculosis presents the most challenging situation in this regard, as it has many ACs. Linking individual ACs with specific regulatory outcomes is important for understanding cAMP signal transduction from a mechanistic perspective, as well as for the pathogenesis of M. tuberculosis.
Perhaps the most important new frontier will be in understanding the effects of pathogen-mediated cAMP increases in host cells. The large number of pathogens that use this strategy and the diversity of mechanisms that are used point to the effectiveness of this approach. Understanding the consequences of pathogen-mediated manipulation of host cAMP levels may provide new antimicrobial targets as well as important insights into the natural roles of cAMP in regulating innate immunity, as these pathogens can be used to probe the system in both health and disease.
